Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Total Revenue
170,911
174,386
184,305
154,961
Cost of Revenue
104,383
99,036
96,855
87,290
Gross Profit
66,528
75,350
87,450
67,671
Operating Expenses
Research Development
8,335
2,730
10,722
7,409
Selling General and Administrative
20,553
14,112
28,493
19,038
Non Recurring
--
--
1,100
545
Others
0
8,293
(1,100)
0
Total Operating Expenses
28,888
25,135
39,215
26,992
Operating Income or Loss
37,640
50,215
48,235
40,679
Income from Continuing Operations
Total Other Income/Expenses Net
(28,688)
(16,878)
4,611
913
Earnings Before Interest And Taxes
8,952
33,337
52,846
41,592
Interest Expense
21,194
22,842
20,686
20,912
Income Before Tax
(12,242)
10,495
32,160
20,680
Income Tax Expense
(883)
(2,275)
18,138
7,423
Minority Interest
0
--
--
--
Net Income From Continuing Ops
(11,359)
12,770
14,022
13,257
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(11,359)
12,770
14,022
13,257
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(11,359)
12,770
14,022
13,257